This article is available to subscribers. Subscribe now. Already have an account? Sign in

PerspectiveFree Preview

Our Other Prescription Drug Problem

List of authors.
  • Anna Lembke, M.D.,
  • Jennifer Papac, M.D.,
  • and Keith Humphreys, Ph.D.

The adverse effects of benzodiazepine overuse, misuse, and addiction continue to go largely unnoticed. Efforts to reduce overprescribing of opioids and educate the medical and lay communities about their risks could be expanded to target benzodiazepines as well.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available at NEJM.org.

Author Affiliations

From the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford (A.L., J.P., K.H.), and the Veterans Affairs Palo Alto Health Care System (K.H.) — both in California.

Print Subscriber? Activate your online access.